News

05.02.2017

Availability issues for approved drugs. Case study: Nabiximols

By Harriet Doig MS Ireland includes the availability and reimbursement of MS drugs among its priorities as a patient organisation….

MS diagnosis testimony: I feared it was cancer

05.02.2017

By Labinot Demi My name is Labinot Demi, I live in Kosovo and I was diagnosed with multiple sclerosis in…

EMSP 2017 Conference: Registrations open

26.01.2017

We are inviting members, partners and supporters to register for our 2017 Spring Conference. The two-day event is held in Athens,…

26.01.2017

Highlights of MS research in 2016

The MS International Federation (MSIF) and the UK MS Society have captured the highlights of 2016 MS research in two…

EMSP 2017 Conference: Registrations open

26.01.2017

We are inviting members, partners and supporters to register for our 2017 Spring Conference. The two-day event is held in Athens,…

Highlights of MS research in 2016

26.01.2017

The MS International Federation (MSIF) and the UK MS Society have captured the highlights of 2016 MS research in two…

26.01.2017

Let’s stay in touch!

We are inviting you – our valuable member societies – to provide us with your up to date contact details…

Let’s stay in touch!

26.01.2017

We are inviting you – our valuable member societies – to provide us with your up to date contact details…

European Commission publishes guide on biosimilar medicines

25.01.2017

The European Commission has published a Q&A guide on biosimilar medicines for patients. The document is available in seven languages (English, French,…

1 36 37 38 39 40 70